
Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
Oncology Today with Dr Neil Love
00:00
DEFY efficacy and response rates
Ratan summarizes DEFY results: 41% response with niragestat versus 8% placebo and median PFS not reached.
Play episode from 03:25
Transcript


